Interestingly, in a breast cancer model, BafA1 treatment reduces the growth in cells expressing membrane-tethered, constitutively active NOTCH1 forms, while sparing cells expressing cytoplasmic forms [107]. Here, NOTCH1 is linked to breast carcinoma.